AzTrials
AzTrials

Healthy SubjectsNCT01297023

Human Intervention Study With Calcium Phosphate and Vitamin D

A study testing calcium phosphate, vitamin d and calcium phosphate and vitamin d in people with Healthy Subjects, run by University of Jena at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study was conducted to investigate the effect of vitamin d3 alone and in combination with calcium phosphate on bone metabolism and further physiological parameters in healthy subjects. It is postulated that calcium phosphate beneficially influences the bone specific action of vitamin d3. Read more about this study

Who is it for?
Ages 25 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Subjects
What is being tested?
calcium phosphate, vitamin d and calcium phosphate and vitamin d
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteGermany
Study dates
Jan 2011to May 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • healthy subjects

Who cannot join

  • pregnancy, lactation
  • intake of dietary supplements

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Friedrich-Schiller-University Jena, Institute of Nutrition, Department of Nutritional Physiology

    Jena, Thuringia, 07743

Other trials in Germany

About this study

Official title: The Effect of Vitamin D3 Alone and in Combination With Calcium Phosphate on Bone Metabolism in Healthy Adults

The study was conducted to investigate the effect of vitamin d3 alone and in combination with calcium phosphate on bone metabolism and further physiological parameters in healthy subjects. It is postulated that calcium phosphate beneficially influences the bone specific action of vitamin d3.

Being tested
calcium phosphate, vitamin d, calcium phosphate and vitamin d, placebo
Keywords
calcium phosphate, vitamin d3, bone metabolism, human study

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • calcium phosphateDietary supplement

    20 subjects consume for 8 weeks a bread enriched with calcium phosphate [1g calcium/d]

  • vitamin dDietary supplement

    20 subjects consume for 8 weeks a bread with vitamin d3 [10µg/d]

  • calcium phosphate and vitamin dDietary supplement

    20 subjects consume for 8 weeks a bread enriched with calcium phosphate [1g calcium/d] and vitamin d3 (10µg/d]

  • placeboOther

    All participants consume two weeks before intervention a bread without calcium an vitamin d.

Study groups in NCT01297023
Study groupRoleWhat they receive
calcium phosphateExperimentalNot described
Receives: Dietary Supplement: calcium phosphate
vitamin dExperimentalNot described
Receives: Dietary Supplement: vitamin d
calcium phosphate and vitamin dExperimentalNot described
Receives: Dietary Supplement: calcium phosphate and vitamin d
placeboPlacebo comparatorNot described
Receives: Other: placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. bone resorption and bone formation markers in blood and urine

    Measured: 8 weeks

Secondary outcomes (2)
  1. concentration of minerals in blood, stool and urine

    Measured: 8 weeks

  2. blood lipids

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Feb 2011 (estimated)
  2. Study startJan 2011
  3. Primary completionApr 2011
  4. Study completionMay 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01297023
Sponsor's protocol ID
LSEP H47-11
Status last verified
Nov 2012
First submitted
15 Feb 2011
Last updated
7 Nov 2012
Results posted
No
Data monitoring committee
Yes

Publications

  • Trautvetter U, Neef N, Leiterer M, Kiehntopf M, Kratzsch J, Jahreis G. Effect of calcium phosphate and vitamin D(3) supplementation on bone remodelling and metabolism of calcium, phosphorus, magnesium and iron. Nutr J. 2014 Jan 17;13:6. doi: 10.1186/1475-2891-13-6.

    PubMed 24438153

Questions about this trial

What is this clinical trial studying?

A study testing calcium phosphate, vitamin d and calcium phosphate and vitamin d in people with Healthy Subjects, run by University of Jena at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Nov 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

bone resorption and bone formation markers in blood and urine (time frame: 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01297023, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Nov 2012.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in